Article
A place for precision medicine in bladder cancer: targeting the FGFRs.
Future oncology (London, England) - 1 Oct 2016
di Martino Erica, Tomlinson Darren C, Williams Sarah V, Knowles Margaret A
Abstract excerpt
Bladder tumors show diverse molecular features and clinical outcome. Muscle-invasive bladder cancer has poor prognosis and novel approaches to systemic therapy are urgently required. Non-muscle-invasive bladder cancer has good prognosis, but high recurrence rate and the requirement for life-long disease monitoring places a major burden on patients and healthcare providers. Studies of tumor tissues from both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.